Scientists proposed an ‘all-purpose’ nanostrategy based on dose deposition enhancement, cell cycle arrest, and ROS production as prostate cancer radiosensitizer for potential clinical translation.
[Nanoscale]
Sorry, but the selected Zotpress account can't be found.
